RINGTX Trademark
RINGTX is a USPTO trademark filed by Ring Therapeutics, Inc.. Status: Pending.
Trademark Facts
| Mark | RINGTX |
|---|---|
| Serial Number | 99022541 |
| Status | Pending |
| Filing Date | 2025-01-29 |
| Mark Type | Stylized |
| Nice Classes | 005 (Pharmaceuticals), 040 (Material Treatment) |
| Owner | Ring Therapeutics, Inc. |
| Attorney of Record | Christina M. Licursi |
| Prosecution Events | 19 |
| Latest Event | EEXT on 2026-04-17 |
Goods & Services
Custom manufacture of anelloviruses; Encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of human diseases and disorders; pharmaceutical preparations for use in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune diseases, autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases